Allergic Asthma—Diagnosis, Management, and Monitoring

Allergic Asthma—Diagnosis, Management, and Monitoring
Please read through the following information and click continue.

ACPE Universal Program Number: 207-000-07-006-H04
Release Date: June 1, 2007
Expiration Date: June 1, 2010


Description
Asthma is a reversible, obstructive airway disease that impacts a wide range of the United States population. In some patients, asthma symptoms can be worsened or precipitated by exposure to allergens. This is defined as allergic asthma, and special consideration should be made to control asthma in this patient population. Patient specific considerations must be made when selecting drug therapy. Appropriate follow-up and monitoring should be conducted to ensure goals of therapy are met for each individual patient.

Learning Objectives
Upon successful completion of this activity, the pharmacist should be better able to:

  1. Describe the epidemiology and pathophysiology of allergic asthma.
  2. Understand how allergic asthma presents and is diagnosed.
  3. Provide both non-pharmacological and pharmacological treatment plans for the management of allergic asthma.
  4. Recommend and perform appropriate monitoring to determine if goals of therapy are achieved for allergic asthma.

Target Audience
The target market for this program is pharmacists.

Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  • Review the content of the activity.
  • Successfully complete the post-test (70% or higher).
  • You will have two (2) opportunities to successfully complete the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Accreditation

Pharmacists
ACPE logoNCPA is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 2.0 contact hours (.2 CEUs) of continuing pharmacy education credit under the number 207-000-07-006-H04.

 

Faculty
Casey Gallimore, PharmD, and Vibhuti Arya, PharmD, are pharmaceutical care leadership residents, and Todd D. Sorensen, PharmD, is an associate professor and director, pharmaceutical care residency program, at the University of Minnesota College of Pharmacy, Minneapolis, Minnesota.

Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.

Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.


Software Requirements

PC
Windows 2000
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader

MAC
Mac OS 10.2.8
Safari
*Adobe Acrobat Reader

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 

 

 

 

Continue